Assignee
FIBROSTATIN S L
ES·4 granted patents·5 pending applications·4 citations·filing 2013–2018
Top patents by PatentIndex Score
9 records- 0170US9066938B2GPBP-1 inhibition and its therapeutic useFIBROSTATIN S L·Filed 2013·Granted Jun 30, 2015·4 cites·35 claims
- 0256US10544083B2GPBP inhibition using Q2 peptidomimeticsFIBROSTATIN S L·Filed 2018·Granted Jan 28, 2020·0 cites·19 claims
- 0355US9199936B2GPBP inhibition using Q2 peptidomimeticsFIBROSTATIN S L·Filed 2013·Granted Dec 1, 2015·0 cites·18 claims
- 0452US10633455B2Method for treating and diagnosing disease using inhibitors of goodpasture antigen binding proteinFIBROSTATIN S L·Filed 2017·Granted Apr 28, 2020·0 cites·8 claims
- 0550US2015093378A1Goodpasture Antigen Binding Protein Detection and Inhibition and its Use in DiabetesFIBROSTATIN S L·Filed 2014·Application pending·0 cites
- 0647US2016083327A1GPBP inhibition using Q2 peptidomimeticsFIBROSTATIN S L·Filed 2015·Application pending·0 cites
- 0743US2017204197A1Goodpasture Antigen Binding Protein Detection and Inhibition and its Use in DiabetesFIBROSTATIN S L·Filed 2017·Application pending·0 cites
- 0841US2015320730A1GPBP-1 inhibition and its therapeutic useFIBROSTATIN S L·Filed 2015·Application pending·0 cites
- 0929US2016184274A1Methods for inhibiting mesenchymal phenotype after epithelial-to-mesenchymal transitionFIBROSTATIN S L·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →